
Layla D. Berry
Examiner (ID: 16889, Phone: (571)272-9572 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1609, 1623, 1693 |
| Total Applications | 1713 |
| Issued Applications | 1092 |
| Pending Applications | 106 |
| Abandoned Applications | 561 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9174992
[patent_doc_number] => 20130316977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'PRIMING SOLUTIONS FOR CARDIOPULMONARY BYPASS'
[patent_app_type] => utility
[patent_app_number] => 13/634934
[patent_app_country] => US
[patent_app_date] => 2011-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7441
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13634934
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/634934 | Priming solutions for cardiopulmonary bypass | Nov 6, 2011 | Issued |
Array
(
[id] => 8968640
[patent_doc_number] => 08507451
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-08-13
[patent_title] => 'Method for the treatment of type II diabetes'
[patent_app_type] => utility
[patent_app_number] => 13/279468
[patent_app_country] => US
[patent_app_date] => 2011-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3620
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13279468
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/279468 | Method for the treatment of type II diabetes | Oct 23, 2011 | Issued |
Array
(
[id] => 9094902
[patent_doc_number] => 20130274213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'GLYCOSYLATED AMINOCOUMARINS AND METHODS OF PREPARING AND USES OF SAME'
[patent_app_type] => utility
[patent_app_number] => 13/879071
[patent_app_country] => US
[patent_app_date] => 2011-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6755
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879071
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/879071 | Glycosylated aminocoumarins and methods of preparing and uses of same | Oct 16, 2011 | Issued |
Array
(
[id] => 7768371
[patent_doc_number] => 20120035345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'PROCESS FOR PREPARING GLYCOPEPTIDES HAVING ASPARAGINE-LINKED OLIGOSACCHARIDES, AND THE GLYCOPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/273786
[patent_app_country] => US
[patent_app_date] => 2011-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18720
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20120035345.pdf
[firstpage_image] =>[orig_patent_app_number] => 13273786
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/273786 | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides | Oct 13, 2011 | Issued |
Array
(
[id] => 7757446
[patent_doc_number] => 20120029181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'SYNTHESIS OF 5-AZACYTIDINE'
[patent_app_type] => utility
[patent_app_number] => 13/273127
[patent_app_country] => US
[patent_app_date] => 2011-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4774
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20120029181.pdf
[firstpage_image] =>[orig_patent_app_number] => 13273127
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/273127 | SYNTHESIS OF 5-AZACYTIDINE | Oct 12, 2011 | Abandoned |
Array
(
[id] => 7711793
[patent_doc_number] => 20120004158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'Quaternised Ammonium Cyclodextrin Compounds'
[patent_app_type] => utility
[patent_app_number] => 13/234912
[patent_app_country] => US
[patent_app_date] => 2011-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7030
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13234912
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/234912 | Quaternised Ammonium Cyclodextrin Compounds | Sep 15, 2011 | Abandoned |
Array
(
[id] => 7784685
[patent_doc_number] => 20120046241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-23
[patent_title] => 'DOSE OF AVE5026 FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH SEVERE RENAL IMPAIRMENT'
[patent_app_type] => utility
[patent_app_number] => 13/231364
[patent_app_country] => US
[patent_app_date] => 2011-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2245
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20120046241.pdf
[firstpage_image] =>[orig_patent_app_number] => 13231364
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/231364 | DOSE OF AVE5026 FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH SEVERE RENAL IMPAIRMENT | Sep 12, 2011 | Abandoned |
Array
(
[id] => 10547394
[patent_doc_number] => 09271993
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-01
[patent_title] => 'Treatment of bacterial infectious diseases'
[patent_app_type] => utility
[patent_app_number] => 13/820258
[patent_app_country] => US
[patent_app_date] => 2011-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15080
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13820258
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/820258 | Treatment of bacterial infectious diseases | Sep 11, 2011 | Issued |
Array
(
[id] => 8904777
[patent_doc_number] => 20130172280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'HYDROGEN BOND FORMING FLUORO KETOLIDES FOR TREATING DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/821314
[patent_app_country] => US
[patent_app_date] => 2011-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13739
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13821314
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/821314 | Hydrogen bond forming fluoro ketolides for treating diseases | Sep 8, 2011 | Issued |
Array
(
[id] => 7663644
[patent_doc_number] => 20110312913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'METHOD AND PHARMACEUTICAL TO TREAT SPINAL DISCS'
[patent_app_type] => utility
[patent_app_number] => 13/217532
[patent_app_country] => US
[patent_app_date] => 2011-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2483
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20110312913.pdf
[firstpage_image] =>[orig_patent_app_number] => 13217532
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/217532 | METHOD AND PHARMACEUTICAL TO TREAT SPINAL DISCS | Aug 24, 2011 | Abandoned |
Array
(
[id] => 8527964
[patent_doc_number] => 08304534
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-06
[patent_title] => 'Process for producing difructose dianhydride III crystals'
[patent_app_type] => utility
[patent_app_number] => 13/210595
[patent_app_country] => US
[patent_app_date] => 2011-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 10798
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13210595
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/210595 | Process for producing difructose dianhydride III crystals | Aug 15, 2011 | Issued |
Array
(
[id] => 7711861
[patent_doc_number] => 20120004192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'USE OF LACTULOSE IN THE TREATMENT OF AUTISM'
[patent_app_type] => utility
[patent_app_number] => 13/204881
[patent_app_country] => US
[patent_app_date] => 2011-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1633
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13204881
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/204881 | Use of lactulose in the treatment of autism | Aug 7, 2011 | Issued |
Array
(
[id] => 8829955
[patent_doc_number] => 20130131000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'Composition Comprising Ligustroflavone, Rhoifolin and Hyperin and Its Pharmaceutical Application'
[patent_app_type] => utility
[patent_app_number] => 13/816105
[patent_app_country] => US
[patent_app_date] => 2011-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5765
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816105
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/816105 | Composition comprising ligustroflavone, rhoifolin and hyperin and its pharmaceutical application | Aug 3, 2011 | Issued |
Array
(
[id] => 7567985
[patent_doc_number] => 20110288048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'PROMOTER FOR HARD TISSUE FORMATION'
[patent_app_type] => utility
[patent_app_number] => 13/196713
[patent_app_country] => US
[patent_app_date] => 2011-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7561
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20110288048.pdf
[firstpage_image] =>[orig_patent_app_number] => 13196713
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/196713 | Promoter for hard tissue formation | Aug 1, 2011 | Issued |
Array
(
[id] => 11783921
[patent_doc_number] => 09393193
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-19
[patent_title] => 'Compositions for controlling heartworm infestation'
[patent_app_type] => utility
[patent_app_number] => 13/813259
[patent_app_country] => US
[patent_app_date] => 2011-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4906
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813259
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/813259 | Compositions for controlling heartworm infestation | Jul 28, 2011 | Issued |
Array
(
[id] => 9538570
[patent_doc_number] => 20140163217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'PROCESS FOR THE ESTERIFICATION OF HYALURONIC ACID WITH HYDROPHOBIC ORGANIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/813114
[patent_app_country] => US
[patent_app_date] => 2011-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4796
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813114
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/813114 | PROCESS FOR THE ESTERIFICATION OF HYALURONIC ACID WITH HYDROPHOBIC ORGANIC COMPOUNDS | Jul 25, 2011 | Abandoned |
Array
(
[id] => 7720827
[patent_doc_number] => 20120010162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'METHOD FOR TREATMENT OF LUNG INFECTIONS BY ADMINISTRATION OF AMINOGLYCOSIDES BY AEROLISATION'
[patent_app_type] => utility
[patent_app_number] => 13/178930
[patent_app_country] => US
[patent_app_date] => 2011-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14122
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20120010162.pdf
[firstpage_image] =>[orig_patent_app_number] => 13178930
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/178930 | Method for treatment of lung infections by administration of aminoglycosides by aerolisation | Jul 7, 2011 | Issued |
Array
(
[id] => 7807987
[patent_doc_number] => 20120058941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'GLUCOPYRANOSIDE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 13/174814
[patent_app_country] => US
[patent_app_date] => 2011-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59011
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058941.pdf
[firstpage_image] =>[orig_patent_app_number] => 13174814
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/174814 | Glucopyranoside compound | Jun 30, 2011 | Issued |
Array
(
[id] => 10013115
[patent_doc_number] => 09056119
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-16
[patent_title] => 'VEGF production promoter'
[patent_app_type] => utility
[patent_app_number] => 13/805798
[patent_app_country] => US
[patent_app_date] => 2011-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3840
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13805798
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/805798 | VEGF production promoter | Jun 30, 2011 | Issued |
Array
(
[id] => 8951167
[patent_doc_number] => 20130196948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'POLYMERS FOR BIOMATERIALS AND THERAPEUTICS'
[patent_app_type] => utility
[patent_app_number] => 13/806240
[patent_app_country] => US
[patent_app_date] => 2011-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 18230
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13806240
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/806240 | POLYMERS FOR BIOMATERIALS AND THERAPEUTICS | Jun 22, 2011 | Abandoned |